Detalhe da pesquisa
1.
Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial.
Haematologica
; 106(2): 543-554, 2021 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32107341
2.
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.
BMC Immunol
; 21(1): 39, 2020 06 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32600256
3.
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
BMC Cancer
; 19(1): 504, 2019 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31138244
4.
High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany.
Support Care Cancer
; 27(11): 4265-4271, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30859307
5.
Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice.
Eur J Haematol
; 100(5): 455-464, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29393986
6.
Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma.
Eur J Haematol
; 101(1): 12-20, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29575332
7.
Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS study.
Eur J Haematol
; 99(2): 169-177, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28467615
8.
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial.
Br J Haematol
; 171(5): 710-9, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26449739
9.
Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany".
Support Care Cancer
; 28(1): 3-4, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31701271
10.
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
Blood
; 119(21): 4851-9, 2012 May 24.
Artigo
Inglês
| MEDLINE | ID: mdl-22490331
11.
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Ann Hematol
; 93(6): 913-21, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24807241
12.
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
Lancet Haematol
; 11(2): e101-e113, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38302221
13.
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registry.
J Clin Immunol
; 33 Suppl 1: S67-71, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22976553
14.
HIV-associated lung cancer: survival in an unselected cohort.
Scand J Infect Dis
; 45(10): 766-72, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23876190
15.
Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial.
BMC Cancer
; 11: 87, 2011 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-21352561
16.
Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy.
Eur J Haematol
; 85(1): 11-9, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20331739
17.
Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.
Ann Hematol
; 88(1): 51-7, 2009 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-18665360
18.
Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent Prognosis.
Clin Lymphoma Myeloma Leuk
; 19(10): e581-e587, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31377211
19.
Drug-perturbation-based stratification of blood cancer.
J Clin Invest
; 128(1): 427-445, 2018 01 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29227286
20.
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.
Haematologica
; 92(1): 42-9, 2007 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17229634